Medicine Overview

Indication

Know Medicine, Follow Guideline

Adult Dose

Clinical InformationAdministration Information
Indication: Non-small cell lung cancer
Age: Adult
Dose: Oral – 60 mg/m2
Frequency: once weekly for 3 weeks
Note: May increase subsequently to 80 mg/m2 once weekly; if neutrophil count is less than 500 cells/mm3 or between 500-1000 cells/mm3 on 2 separate occasions, keep dose at 60 mg/m2 for next 3 doses.
Indication: Non-small cell lung cancer
Age: Adult
Condition: Massive liver metastases (greater than 75% of liver volume replaced by the tumour)
Dose: Oral – Decrease dose by 1/3
Note: Hepatic impairment adjustment.

Child Dose

Clinical InformationAdministration Information
Age: Pediatric
Dose: No approved pediatric dosage available
Note: Not recommended
Administration
  • For IV use only
  • Must be administered over 6-10 minutes
Side Effect

Drug Interaction

Drug NameRisk Factors
Cisplatin
Increased risk of granulocytopenia
Paclitaxel, itraconazole, ketoconazole
Increased risk of neurotoxicity

Disease Interaction

Disease NameRisk Factors
Severe Current or Recent Infection
Risk of serious infection complications
Neutropenia, Thrombocytopenia
Risk of severe infection and bleeding

Pregnancy

Lactation
Special Use
Precaution
Overdose
Pharmacology
Storage
Intravenous: Store at 2-8°C. Protect from light. Oral: Store at 2-8°C.

Data Sources

Clinical & regulatory information on this page is compiled from the following government sources:

DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.